Pfizer Unveils $1 Billion Manufacturing Facility in Tuas Biomedical Park

Pfizer Unveils $1 Billion Manufacturing Facility in Tuas Biomedical Park

23 Jul, 2024

 Pfizer Unveils $1 Billion Manufacturing Facility in Tuas Biomedical Park

Pfizer has opened a new $1 billion Active Pharmaceutical Ingredient (API) manufacturing facility in Tuas Biomedical Park, Singapore. The 429,000 sq ft facility will produce small molecule APIs for oncology, pain, and antibiotic medicines, creating over 250 jobs. Designed for future expansions, it includes processing suites, a warehouse, and energy-efficient technologies. The facility holds a Green Mark Gold certification, underscoring Pfizer's commitment to sustainability.

Related News

Singapore Budget 2025 Enhanced support for businesses and households unveiled

19 Feb, 2025

Singapore Budget 2025 introduces enhanced support for businesses and households…
Read More
SICCI Drives New Opportunities and Business Ties Says Singapore Official

28 Jan, 2025

The Singapore Indian Chamber of Commerce and Industry (SICCI), celebrating…
Read More
Singapore President’s Visit Strengthens Ties with Odisha for Future Collaborations

22 Jan, 2025

President of Singapore, Mr. Tharman Shanmugaratnam, recently visited the World…
Read More
Grab Partners with London School of Business for Education Programmes

08 Jan, 2025

Grab has partnered with the London School of Business and…
Read More
Singapore Tech Start-ups Expanding Presence in the US, Reports SBF

02 Jan, 2025

Many local tech start-ups in Singapore are looking to expand…
Read More
Atome, Valiram Partner for Flexible Financial Services in Malaysia, Singapore

05 Dec, 2024

Atome, a leading financial services platform, has partnered with Valiram,…
Read More

Interview

© 2025 Business International News. All rights reserved | Powered by Cred Matters.